RAD1P2

Across TCGA pan-cancer cohorts, RAD1P2 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RAD1P2 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RAD1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RAD1P2 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUAD show a favorable association.

KICH, SKCM, and LUAD are the cancer types where RAD1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	OS	Tertile	All	0.827	0.981	.003	68	view →
SKCM	OS	Median	All	0.404	0.271	<.001	51	view →
LUAD	DFS	Quartile	II,III,IV	0.493	0.230	.005	38	view →
UCS	DFS	Median	II,III,IV	0.504	0.154	.003	36	view →
LGG	DFS	Median	All	0.880	0.780	<.001	33	view →
ACC	DFS	Tertile	IV	0.012	0.310	.002	18	view →
ESCA	DFS	Median	III,IV	0.449	0.232	.009	18	view →
LAML	DFS	Median	All	0.663	0.470	.010	18	view →
BLCA	DFS	Quartile	III,IV	0.400	0.131	.018	14	view →
LIHC	DFS	Tertile	III,IV	0.088	0.342	<.001	9	view →
READ	DFS	Tertile	IV	0.095	0.697	.014	9	view →
KIRC	OS	Tertile	All	0.564	0.727	.009	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RAD1P2–KICH (OS)

Open the KICH breakdown →